Taken together, our proteomic screen suggests a common mechanism of AGR2 acting over FLNA and NPM3 proteins in SW480 and SW620 colorectal cancer cell models, as demonstrated by both the overexpression and silencing of AGR2. This evidence concerns the gene AGR2 and colorectal cancer.